Exploring Indicators of Vulnerability in Older Adults With Newly Diagnosed Multiple Myeloma

被引：0
|
作者：
Wildes, Tanya M. [1 ]
机构：
[1] Univ Nebraska Med Ctr, Nebraska Med, Omaha, NE 68198 USA
来源：
JCO CLINICAL CANCER INFORMATICS | 2024年 / 8卷
关键词：
CANCER-TREATMENT; SURVIVAL;
D O I：
10.1200/CCI.24.00013
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Cytogenetics in newly diagnosed multiple myeloma.
    Testoni, N
    Ruggeri, D
    Tosi, P
    Carboni, C
    Iacurti, E
    Martinelli, G
    Ronconi, S
    Cavo, M
    Tura, S
    BLOOD, 1999, 94 (10) : 306B - 306B
  • [22] NEW TREATMENTS FOR NEWLY DIAGNOSED MULTIPLE MYELOMA
    Terpos, Evangelos
    LEUKEMIA RESEARCH, 2016, 49 : S15 - S15
  • [23] Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma
    Sonneveld, Pieter
    Dimopoulos, Meletios A.
    Beksac, Meral
    van der Holt, Bronno
    Aquino, Sara
    Ludwig, Heinz
    Zweegman, Sonja
    Zander, Thilo
    Zamagni, Elena
    Wester, Ruth
    Hajek, Roman
    Pantani, Lucia
    Dozza, Luca
    Gay, Francesca
    Cafro, AnneMaria
    De Rosa, Luca
    Morelli, Annamaria
    Gregersen, Henrik
    Gulbrandsen, Nina
    Cornelisse, Petra
    Troia, Rosella
    Oliva, Stefania
    van de Velden, Vincent
    Wu, KaLung
    Ypma, Paula F.
    Bos, Gerard
    Levin, Mark-David
    Pour, Luca
    Driessen, Christoph
    Broijl, Annemiek
    Croockewit, Alexandra
    Minnema, Monique C.
    Waage, Anders
    Hveding, Cecilie
    van de Donk, Niels W. C. J.
    Offidani, Massimo
    Palumbo, Giuseppe A.
    Spencer, Andrew
    Boccadoro, Mario
    Cavo, Michele
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (32) : 3613 - +
  • [24] Setting the standard for newly diagnosed multiple myeloma
    Jacob Laubach
    Paul G. Richardson
    Kenneth Anderson
    Nature Reviews Clinical Oncology, 2011, 8 : 255 - 256
  • [25] Clinical treatment of newly diagnosed multiple myeloma
    Cejalvo, Maria J.
    de la Rubia, Javier
    EXPERT REVIEW OF HEMATOLOGY, 2015, 8 (05) : 595 - 611
  • [26] Management of multiple myeloma in the newly diagnosed patient
    Mateosi, Maria-Victoria
    San Miguel, Jesus F.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2017, : 498 - 507
  • [27] Daratumumab in untreated newly diagnosed multiple myeloma
    Abdallah, Nadine
    Kumar, Shaji K.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2019, 10
  • [28] The incidence of thromboembolism for lenalidomide versus thalidomide in older patients with newly diagnosed multiple myeloma
    Ang Li
    Qian Wu
    Greg Warnick
    Shan Li
    Edward N. Libby
    David A. Garcia
    Gary H. Lyman
    Annals of Hematology, 2020, 99 : 121 - 126
  • [29] HAEMOSTATIC DISORDERS IN NEWLY DIAGNOSED MULTIPLE MYELOMA
    Urnova, E.
    Mendeleeva, L.
    Gracheva, M.
    Pokrovskaya, O.
    Vasiliev, S.
    Gemdjian, E.
    Tarandovskii, I.
    Sinauridze, E.
    Savchenko, V.
    HAEMATOLOGICA, 2014, 99 : 653 - 653
  • [30] Individualized risk in newly diagnosed multiple myeloma
    Maura, Francesco
    Rajanna, Arjun
    Ziccheddu, Bachisio
    Derkach, Andriy
    Poos, Alexandra
    Maclachlan, Kylee
    Boyle, Eileen
    Hultcrantz, Malin
    Silva, Ariosto
    Jackson, Graham
    Kaiser, Martin
    Pawlyn, Charlotte
    Cook, Gordon
    Bergsagel, Leif
    Goldschmidt, Hartmut
    Weisel, Katja
    Fenk, Roland
    Mai, Elias
    Raab, Marc
    van Rhee, Frits
    Usmani, Saad
    Shain, Ken
    Weinhold, Niels
    Morgan, Gareth
    Landgren, Ola
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S236 - S236
12345